Company profile: Health Decisions
1.1 - Company Overview
Company description
- Provider of full-service contract research organization services specializing in clinical studies of therapeutics for women’s health and diagnostics across all therapeutic areas; focused on women’s health for over 28 years with more than 100 trials in women-only indications such as contraception, serving forward-looking biopharma and medical device companies and supporting modernization of clinical development.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Health Decisions
Cognivia
HQ: Belgium
Website
- Description: Provider of analytical tools and services to optimize and speed clinical development of novel medicines, including Placebell to reduce data variability by addressing placebo response and patient heterogeneity; Compl-AI to predict non-adherence and dropout risks to aid patient engagement; and an Expert Analysis Service to detect and explain clinical site variability and help adjust data for clearer study results.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cognivia company profile →
Curia
HQ: United States
Website
- Description: Provider of contract research, development, and manufacturing services for pharmaceutical and biopharmaceutical customers, covering discovery biology, synthetic and medicinal chemistry, and small-scale and commercial manufacturing. Formerly AMRI, Curia delivers offerings from R&D through commercial manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curia company profile →
Aldevron
HQ: United States
Website
- Description: Provider of contract manufacturing and scientific services in cell and genetic engineering, specializing in plasmid DNA, protein/enzyme production, and antibody generation. Offers plasmid DNA manufacturing (research to clinical), nanoplasmid design/retrofit, mRNA manufacturing and encapsulation, CRISPR nucleases, RNP complexes, and in vitro transcription and capping enzymes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aldevron company profile →
Mithra Pharmaceuticals
HQ: Belgium
Website
- Description: Provider of women's health care products focused on contraception, fertility, and menopause. Pipeline centers on an Estetrol (E4) platform with lead development candidates Estelle, a fifth-generation oral contraceptive, and Donesta, a next-generation hormone therapy for menopausal symptoms. Portfolio also includes the Myring contraceptive vaginal ring, Tibelia for menopause, and Zoreline biodegradable implants for hormone-dependent cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mithra Pharmaceuticals company profile →
Pharmalog
HQ: Germany
Website
- Description: Provider of clinical research services as a clinical research organization, conducting Phase I and Phase II–IV trials for pharmaceutical and biotechnology companies, as well as non-interventional (NIS) studies. Offers research programs, special trials including dermatological/cosmetic studies, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmalog company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Health Decisions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Health Decisions
2.2 - Growth funds investing in similar companies to Health Decisions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Health Decisions
4.2 - Public trading comparable groups for Health Decisions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →